美国FDA药品数据库(U.S. FDA Drugs Database)
检索条件: 药品名称=LIPTRUZET
符合检索条件的记录共4
1 页 当前第 1 页  返回检索页
1药品名称LIPTRUZET
申请号200153产品号001
活性成分ATORVASTATIN CALCIUM; EZETIMIBE市场状态停止上市
剂型或给药途径TABLET;ORAL规格EQ 10MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期2013/05/03申请机构MERCK SHARP AND DOHME CORP
2药品名称LIPTRUZET
申请号200153产品号002
活性成分ATORVASTATIN CALCIUM; EZETIMIBE市场状态停止上市
剂型或给药途径TABLET;ORAL规格EQ 20MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期2013/05/03申请机构MERCK SHARP AND DOHME CORP
3药品名称LIPTRUZET
申请号200153产品号003
活性成分ATORVASTATIN CALCIUM; EZETIMIBE市场状态停止上市
剂型或给药途径TABLET;ORAL规格EQ 40MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期2013/05/03申请机构MERCK SHARP AND DOHME CORP
4药品名称LIPTRUZET
申请号200153产品号004
活性成分ATORVASTATIN CALCIUM; EZETIMIBE市场状态停止上市
剂型或给药途径TABLET;ORAL规格EQ 80MG BASE;10MG **Federal Register determination that product was not discontinued or withdrawn for safety or efficacy reasons**
治疗等效代码参比药物
批准日期2013/05/03申请机构MERCK SHARP AND DOHME CORP